Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA labels broccoli sold at Walmart
FDA is recalling more than 32,000 packages of these popular breadcrumbs sold nationwide
The California-based company has recalled 26,400 eight-ounce packages of its Unseasoned Bread Crumbs (Pan Rayado) and 6,240 eight-ounce packages of its Seasoned Bread Crumbs (Pan Rayado Sazonado) because the products contain sesame as an “undeclared allergen” identified as sesame.
Walmart broccoli sold in Texas labeled as deadly. See list of FDA recalls so far in 2025
Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued by the agency.
FDA labels broccoli sold at Walmart as deadly. See where it was sold and what you should do
The U.S. Food and Drug Administration has labeled the broccoli recall as a Class I, the highest risk level issued by the agency.
Pig Kidney Transplant Trials Given FDA Approval in US
FDA OKs clinical trials for pig kidney transplants in people
The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in cross-species transplantation.
FDA approves pig organ transplant trials for patients with kidney failure
The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a long wait for human organ transplants.
FDA Approves Clinical Trials for Pig Kidney Transplants in Humans
TUESDAY, Feb. 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in cross-species transplantation.
FDA Approves Susvimo For Diabetic Macular Edema Treatment
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susv
With FDA approval, Genentech turns eye implant's focus to diabetes
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already-approved drug to head off the leading cause of blindness in people with diabetes.
Genentech : FDA Approves Susvimo For Diabetic Macular Edema Treatment
Genentech, a member of the Roche Group (RHHBY), announced that the U.S. Food and Drug Administration has approved Susvimo
4h
on MSN
Nut Recall Update for 8 States As FDA Sets Risk Level
A pecan nut product that was recalled due to undeclared walnuts has been given a Class II classification by the food agency.
MedPage Today
7h
FDA OKs New Wearable Treatment for Parkinson's Disease
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
Healio
10h
FDA accepts BLA for Leqembi subcutaneous autoinjector maintenance dosing
The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...
12h
Hushpuppy Recall Update as FDA Sets Highest Risk Level
Millions of people in the United States have food allergies or food sensitivities, and undeclared allergens are the most common reason for food recalls, according to the FDA. Food sensitivities can ...
12h
on MSN
Dr. Gupta details new FDA-approved pain medication with no opioids
The US Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades ...
Healio
12h
FDA clears first assay designed to measure lipoprotein(a) in nanomoles
Roche announced its next generation assay received FDA 510(k) clearance for the measurement of lipoprotein(a) for assessment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Recall
Food and Drug Administration
Journavx
Ozempic
Clinical trial
Feedback